Tagged with

Taiwan Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision for the future growth of the company through partnerships with big pharmaceutical companies. Could you introduce yourself to our executive…

Colombia Aurobindo’s regional head, Kamlesh Thakkar, discusses how the company is truly benefiting the healthcare landscape in Colombia, while describing his experience in changing the mindset concerning the use of generics in the top hospitals of the country and shares the origins of Aurobindo’s healthier life campaign. To begin, Mr. Thakkar,…

Taiwan Michael H.J. Lai, Founder of Body Organ Biomedical Corporation, discusses Ologen’s success as the first ever eye tissue repair product and highlights the importance of global exposure for Taiwan-based companies. Can you introduce the company to our readers? What was your vision at the time you started the company? “Eye…

Indonesia Jorge Wagner, President Director at Boehringer Ingelheim Indonesia, explains the importance of innovation within the universal healthcare coverage program that is being implemented in Indonesia. He also illustrates how the affiliate has been one of the fastest-growing pharmaceutical companies in Indonesia during the period 2015-2016. With recent changes at the…

Taiwan Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you introduce yourself and Visgeneer to our readers? What have been the main milestones for the company so far? “Visgeneer believes that…

Colombia Regional leader of Boston Scientific’s Andean Region, Fernando Dussan, share his insights on why Colombia is suitable to host the core business of Boston Scientific. He speaks about the company’s expansive portfolio, the key challenges in the ecosystem, as well as building a holistic partnership that places the patients at…

Taiwan Taiwan macroeconomic snapshot.   Taiwan is highly ranked in a number of international competitiveness indicators such as knowledge economy, investment environment, and cluster development.       Taiwan is located within short flight distance of a number of major Asian cities.     Recent IPOs in Taiwanese life sciences.  …

Taiwan Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future growth. Can you introduce MegaPro Biomedical to our readers? “Nanosize features many advantages; amongst them I would highlight the ability…

Taiwan Daniel Huang, CEO of Genomics Bioscience, Taiwan’s largest commercial genome sequencing company, and Chairman of Pharmigene, a global leader in the development and manufacturing of genetic tests, documents how he plans to leverage the combined capacity and expertise of these two companies to form strategic alliances with leading pharmaceutical companies…

Ukraine Victoria Tarabanova, country manager of the Ukrainian office of Wörwag Pharma, a company dedicated to treating diabetic comorbidities such as neuropathic, cardiovascular and neurological diseases, provides insights into the company’s remarkable efforts to enhance Ukraine’s health ecosystem and its enduring commitment to Ukrainian patients and physicians – even during the…

Taiwan Yvonne Huang, VP of Aquavan, a company developing the most sophisticated high-tech green biotechnology platform for the extraction of plants, discusses their innovative technology and business scope while contributing to the concept of improving the health of patients without harming the environment. Can you introduce us to Aquavan? Aquavan is…

Hong Kong Albert Yu, Chairman of the Hong Kong Biotechnology Organization, shares his insights on Hong Kong’s potential to become an innovation hub for the region while positioning Hong Kong as the ‘Chinese City outside of China.’ In addition, he discusses the main trends that will drive development of HK’s biotechnology sector…